血小板

In this prospective, monocentric study, 17 PCFPs in 16 patients were embolized during anticoagulant or antiplatelet therapy.

在预期的单中心研究中，在运用抗凝血剂或抗血小板治疗期间，给16个病人实施的17次PCFP治疗发生了栓塞。

ResultsIn contrast with model group, Myricetin Dispersible Tablets(140 mg/kg,70 mg/kg and 35 mg/kg could significantly decrease the cerebral water content, MDA and LA contents, as well as the weight of venous thrombus , suppress MAO activity, and significantly increase SOD activity.

结果与模型组相比，杨梅素分散片各剂量组(140，70，35 mg/kg)均可显著改善脑水肿、减少过氧化脂质的形成，减少乳酸的聚积，并对单胺氧化酶有抑制作用；显著减轻大鼠静脉血栓重量；显著抑制ADP诱导的血小板聚集。

objectiveto investigate the effect of myricetin dispersible tablets on experimental cerebral ischemia-reperfusion injury in rats and thrombosis formation.methodsexperimental cerebral ischemia-reperfusion injury model was induced by ligation bilateral common carotid arteries. the protective effect of myricetin dispersible tablets was observed by detecting the content of cerebral water, sod and mao activities,mda and la contents.

方法采用双侧颈总动脉结扎法制备大鼠实验性全脑缺血再灌注损伤模型，通过测定大鼠脑含水量，超氧化物歧化酶、单胺氧化酶的活性和丙二醛、乳酸的含量，观察杨梅素分散片对大鼠实验性脑缺血的影响；采用体内静脉血栓形成法，观察杨梅素分散片对体内静脉血栓形成的影响；并研究其对血小板聚集的影响。

MethodsExperimental cerebral ischemia-reperfusion injury model was induced by ligation bilateral common carotid arteries. The protective effect of myricetin dispersible tablets was observed by detecting the content of cerebral water, SOD and MAO activities,MDA and LA contents.

方法采用双侧颈总动脉结扎法制备大鼠实验性全脑缺血再灌注损伤模型，通过测定大鼠脑含水量，超氧化物歧化酶、单胺氧化酶的活性和丙二醛、乳酸的含量，观察杨梅素分散片对大鼠实验性脑缺血的影响；采用体内静脉血栓形成法，观察杨梅素分散片对体内静脉血栓形成的影响；并研究其对血小板聚集的影响。

Barkun and his colleagues, including Nadeem Hussain, a clinician at the Uniersity of Western Ontario, compared the use of antiplatelets in patients who experienced bleeding with those who did not.

Barkun和他的同事们，包括Nadeem Hussain，一位西安大略大学的临床医师，把经历过出血的病人分为使用抗血小板药物组和没有使用组，然后让这两组进行比较。

To study the effect of natrahagin, a Chinese cobra venom proteinase purified from Naja naja atra Z venom on platelet aggregation,fibrinogen level and artery thrombosis.

研究从中国黑眼镜蛇毒中纯化的中国黑眼镜蛇毒蛋白酶natrahagin对血小板聚集，血浆纤维蛋白原水平和动脉血栓形成的影响。

The authors note that the increase in the diameter stenosis in patients on antiplatelet therapy was unexpected, and could be "related to asodilatation caused by dipyridamole or neurohumoral effects on coronary arteries after MI."

作者指出，抗血小板治疗患者直径狭窄增加是意料之外的，可能&与潘生丁引起的血管扩张或心肌梗死后神经体液因素对冠状动脉的影响有关。&

The treated with glucocorticoid and combined therapy such as anti platelet aggregation, scavenging free radicals, reducing intracranial pressure, improving microcirculation and promoting neuronic metabolism, the condition get better.

经糖皮质激素以及抗血小板聚集、清除自由基、降低颅内压、改善微循环等综合治疗，病情明显改善。

Methods and Results— Patients undergoing nonurgent PCI of a native coronary artery were randomized to receive adjunctive therapy with bivalirudin or UFH ＋ eptifibatide.

作者对接受非紧急冠状动脉 PCI 手术的患者随机分组，分别给予比伐卢定或者低分子量肝素＋依替巴肽的辅助治疗，观察PCI手术期间辅助治疗的应用对炎症标志物以及血小板活化的影响。

Results:The main clinical features including fever ( 86.7%), lymphnode enlargement( 66.7%), weight loss(40.0%), fungal infection (40.0%), leucopenia ( 53.3%), normocytic and normochromatic anemia(80.0%), thrombocytopenia(40.0%).

结果 ：15例患者中发热 13例( 86 。7%)，淋巴结肿大 10例( 6 6 。7%)，消瘦 6例( 4 0 。0 %)，真菌感染 6例( 4 0 。0 %)，白细胞减少 8例( 5 3.3%)，贫血 12例( 80 。0 %)，为正常细胞正常色素性贫血，血小板减少 6例( 4 0 。0 %)，骨髓有核细胞增生、浆细胞增多及病态造血，免疫学检查主要为细胞免疫缺陷。

We are in a real jam.

我们的麻烦大了。

Hey, it's Ahmet from India, that foreign exchange guy.

看，那是印度的阿曼特，国际交换生